Por: Fox Business Business November 09, 2023
Graviton Biopharmaceuticals Holdings CEO Sam Waksal argues there will be 'great growth' in the pharmaceutical industry. The Food and Drug Administration (FDA) approved Eli Lilly's drug tirzepatide Wednesday for the . The injection, which will be sold under the brand name Zepbound, was approved specifically for adults with obesity or those who are overweight and also deal with weight-related medical issues such as hypertension,... + full article
Los Angeles Times USA Science November 09, 2023
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide. The drug helped dieters lose about a quarter of their body... + más
Popular diabetes drug Mounjaro could be FDA-approved for weight loss this year, company says | ABC News
Lawsuit filed against makers of Ozempic, Mounjaro over claims of 'gastrointestinal side effects' | ABC News
ABC7 USA Health November 08, 2023
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide. The drug helped dieters lose about a quarter of their body... + más
CBS News USA Health November 08, 2023
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well.While Mounjaro had already been used by some patients off-label for... + más
Eli Lilly Stock Jumps on Obesity Drug’s FDA Approval | MarketWatch
FDA approves new version of diabetes drug Mounjaro for weight loss | Los Angeles Times
10 WBNS USA Nation November 08, 2023
WASHINGTON — A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or tirzepatide. The drug about a quarter of their body... + más
Newsweek USA Nation April 29, 2023
A weight loss drug going through clinical trials could be five times as profitable as other popular weight loss drugs on the market because of its strong success in managing obesity.Originally approved for diabetes management, semaglutide drugs like Ozempic and Wegovy have... + más
What is Ozempic? Why stars risk ‘old face’ for trendy weight-loss drug | New York Post
What To Know About Ozempic: The Diabetes Drug Becomes A Viral Weight Loss Hit (Elon Musk Boasts Using It) Creating A Shortage | Forbes
Orlando Sentinel USA Business April 27, 2023
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment. Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2... + más
NFL Playoff Scenarios | ABC News
Use drugs and surgery early for obesity in kids, new guidance says | Orlando Sentinel
NBC News USA Nation January 01, 2023
An Eli Lilly drug if approved for weight loss could become the best-selling drug of all time, but concerns are mounting about who will actually be able to afford it. Experts are confident that the drug, called tirzepatide, will be granted approval by the Food and Drug... + más
These 2 ETFs show why owning small-cap stocks is key to beating the market at times like this | MarketWatch
About iurex | Privacy Policy | Disclaimer |